1.0022
+0.0451
+(4.71%)
As of 9:43:50 AM EDT. Market Open.
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 4 | 4 | 4 | 4 |
| Avg. Estimate | -0.21 | -0.18 | -0.68 | -0.4 |
| Low Estimate | -0.27 | -0.21 | -0.86 | -0.65 |
| High Estimate | -0.15 | -0.15 | -0.48 | -0.19 |
| Year Ago EPS | -0.54 | -0.51 | -1.59 | -0.68 |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 5 | 5 | 5 | 5 |
| Avg. Estimate | 17.35M | 20.99M | 85.54M | 105.21M |
| Low Estimate | 17M | 19.5M | 84.8M | 101.6M |
| High Estimate | 17.5M | 22M | 86.29M | 109.1M |
| Year Ago Sales | 16.6M | 16.09M | 69.3M | 85.54M |
| Sales Growth (year/est) | 4.51% | 30.47% | 23.43% | 23.00% |
Earnings History
| Currency in USD | 3/31/2024 | 6/30/2024 | 9/30/2024 | 12/31/2024 |
|---|---|---|---|---|
| EPS Est. | -0.51 | -0.47 | -0.42 | -0.22 |
| EPS Actual | -0.54 | -0.51 | -0.42 | -0.23 |
| Difference | -0.03 | -0.04 | -0 | -0.01 |
| Surprise % | -5.63% | -8.05% | -0.96% | -3.60% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -0.21 | -0.18 | -0.68 | -0.4 |
| 7 Days Ago | -0.21 | -0.18 | -0.68 | -0.4 |
| 30 Days Ago | -0.23 | -0.18 | -0.64 | -0.25 |
| 60 Days Ago | -0.23 | -0.18 | -0.64 | -0.25 |
| 90 Days Ago | -0.23 | -0.18 | -0.64 | -0.25 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | 2 | 1 | 1 | -- |
| Up Last 30 Days | 2 | 1 | 1 | 1 |
| Down Last 7 Days | 1 | 2 | 3 | 1 |
| Down Last 30 Days | 1 | 2 | 3 | 2 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| TELA | 61.48% | 65.20% | 57.61% | 41.11% |
| S&P 500 | 6.79% | 5.59% | 9.06% | 14.11% |
Upgrades & Downgrades
| Maintains | Canaccord Genuity: Buy to Buy | 3/21/2025 |
| Maintains | Citizens Capital Markets: Market Outperform to Market Outperform | 3/21/2025 |
| Downgrade | Piper Sandler: Overweight to Neutral | 3/21/2025 |
| Maintains | Piper Sandler: Overweight to Overweight | 11/8/2024 |
| Maintains | Canaccord Genuity: Buy to Buy | 10/4/2024 |
| Maintains | Lake Street: Buy to Buy | 8/13/2024 |
Related Tickers
SGHT Sight Sciences, Inc.
2.6100
0.00%
ELUT Elutia Inc.
2.1316
+1.50%
SIBN SI-BONE, Inc.
13.19
-1.05%
TLSI TriSalus Life Sciences, Inc.
5.58
-2.62%
BDMD Baird Medical Investment Holdings Limited
5.42
+3.24%
IART Integra LifeSciences Holdings Corporation
15.81
+0.38%
CATX Perspective Therapeutics, Inc.
1.8450
-0.27%
NSPR InspireMD, Inc.
2.5350
-2.50%
RXST RxSight, Inc.
14.56
+0.21%
ESTA Establishment Labs Holdings Inc.
31.04
+2.84%